Inhibikase Therapeutics Inc (NASDAQ:IKT) shares, rose in value, with the stock price up by 13.08% to the previous day’s close as strong demand from buyers drove the stock to $1.47. Actively observing the price movement in the last trading, the stock closed the session at
The trading price of Inhibikase Therapeutics Inc (NASDAQ:IKT) floating higher at last check on current market day and closing at $1.61, 34.87% higher than its previous close. Traders who pay close attention to intraday price movement should know that it has been fluctuating between $1.38
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.
